Mortality in Tuberous Sclerosis Complex in the United Kingdom 2016-2022

Kidson, Callum, Ron, Loh Ne and Syed, Yasir Ahmed ORCID: https://orcid.org/0000-0001-9495-307X 2025. Mortality in Tuberous Sclerosis Complex in the United Kingdom 2016-2022. Journal of Intellectual Disability Research 10.1111/jir.13225

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (478kB) | Preview

Abstract

Background Tuberous sclerosis complex (TSC) is a genetic condition caused by mutations in either TSC1 or TSC2 genes, affecting around two million people globally. This study aims to examine causes of death in TSC and explore factors contributing to mortality in people with TSC in the United Kingdom in recent years following updated management and surveillance guidelines for the condition. Methods Comprehensive analysis of the available medical records of the people seen at the largest lifespan TSC clinic in the United Kingdom who passed away between 2016 and 2022 was conducted. Disease-related factors were identified, and the cause of death was determined. Where mortality cause was unobtainable, information was sought from the person's general practitioner, or their death certificate was obtained from the General Registry Office. Subsequently, the cohort was divided into subgroups to investigate potential risk factors for premature mortality. Our results were compared to that of previous TSC mortality studies. Results The study consisted of 19 deaths. Nine deaths were unequivocally attributed to TSC. These fatalities were due to epilepsy (n = 3/19), aspiration pneumonia (n = 3/19), SEGA (n = 1/19), hepatic AML (n = 1/19) and pNET (n = 1/19). Other causes included malignant cancer (n = 6/19), sepsis (n = 2/19), COVID-19 (n = 1/19) and stroke (n = 1/19). Renal failure was a secondary cause in two deaths. Discussion Compared to limited previous mortality studies, this cohort appears to be less affected by SUDEP. This group is also more greatly affected by cancer and presents a potential link between early mortality and renal AML size. Moreover, a clearer role of intellectual disability in mortality of people with TSC may have been identified. Most causes of mortality in this TSC cohort are potentially prevented with suitable interventions earlier.

Item Type:	Article
Date Type:	Published Online
Status:	In Press
Schools:	Schools > Biosciences
Publisher:	Wiley
ISSN:	0964-2633
Date of First Compliant Deposit:	27 February 2025
Date of Acceptance:	26 February 2025
Last Modified:	20 Mar 2025 16:55
URI:	https://orca.cardiff.ac.uk/id/eprint/176508

Actions (repository staff only)

Edit Item